Tough Choices Face Next Head Of NSF

As six-year term ends, Bloch wins praise for raising NSF's profile, but questions remain on how to set priorities WASHINGTON -- You won't see this advertisement in the classified section of any newspaper or magazine. But it describes the type of person that the scientific community hopes will become the next director of the National Science Foundation. The six-year term of the current office holder, Erich Bloch, expires this coming August, and - although there has been no official announcemen

Written byJeffrey Mervis
| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share


As six-year term ends, Bloch wins praise for raising NSF's profile, but questions remain on how to set priorities
WASHINGTON -- You won't see this advertisement in the classified section of any newspaper or magazine. But it describes the type of person that the scientific community hopes will become the next director of the National Science Foundation.

The six-year term of the current office holder, Erich Bloch, expires this coming August, and - although there has been no official announcement - OSTP director Allan Bromley has begun a low-keyed but aggressive search for his successor, who is appointed by the president and must be confirmed by the Senate.

Already, several scientific societies have drafted letters containing the names of people that they would like to see on any short list of candidates. And Bromley says he has asked Mary Good, senior vice president for technology at Allied-Signal Inc. and president ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies